Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 April 2024 | Story DR NITHA RAMNATH

The Vice-Chancellor and Principal of the University of the Free State, Prof Francis Petersen, has the pleasure of inviting you to a guest lecture presented by H.E. Dr Reuben E Brigety, the United States Ambassador to South Africa.

Date: Tuesday 23 April 2024
Time: 15:00-16:00
Venue: Centenary Complex, Bloemfontein Campus

RSVP here by no later than 19 April 2024.


About the speaker

Reuben E Brigety II was confirmed as the 29th United States Ambassador to the Republic of South Africa on 21 July 2022.

Previously, he served as the 17th Vice-Chancellor of the University of the South and Mayor of Sewanee from June 2020 until December 2021, and as the Dean of the Elliott School of International Affairs of the George Washington University from 2015 to 2020. Ambassador Brigety’s most recent diplomatic assignment was serving as the US Representative to the African Union and US Permanent Representative to the UN Economic Commission for Africa from September 2013 to September 2015. Previously, Ambassador Brigety served as the Deputy Assistant Secretary of State in the Bureau of African Affairs and as Deputy Assistant Secretary of State in the Bureau of Population, Refugees, and Migration.

A native of Jacksonville, Florida, Ambassador Brigety also held appointments as Assistant Professor of Government and Politics at George Mason University and at the School of International Service at the American University between August 2003 and April 2009. In addition, Ambassador Brigety was a researcher with the Arms Division of Human Rights Watch (HRW) from August 2001 to May 2003, where he conducted research missions in Afghanistan and Iraq. Before joining HRW, Ambassador Brigety was an active-duty US naval officer and held several staff positions in the Pentagon and in fleet support units.

Ambassador Brigety is a 1995 Distinguished Midshipman Graduate of the US Naval Academy, where he earned a BSc in Political Science (with merit), served as the Brigade Commander, and received the Thomas G Pownall Scholarship. He also holds an MPhil and a PhD in International Relations from the University of Cambridge, England, as well as a Doctor of Humane Letters (honoris causa) from Old Dominion University. Ambassador Brigety is a life member of the Council on Foreign Relations, a recipient of the council’s International Affairs Fellowship, and a fellow of the American Academy of Diplomacy.He is married to Dr Leelie Selassie, and together they have two sons.

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept